Latest Commercialization News

TPG Telecom has unveiled pro forma financials reflecting its recent fibre network sale to Vocus, alongside updated FY25 guidance projecting EBITDA between $1.6 billion and $1.65 billion. The company signals a strategic pivot with fresh investments in satellite technology and IT systems.

Unibail-Rodamco-Westfield N.V. reports a positive net income for the first half of 2025, driven by robust US shopping center performance and strategic investments. The company also advances its ESG commitments and plans to delist from the ASX by August.

Vitrafy Life Sciences announces a leadership change with CEO Kate Munnings retiring and co-founder Brent Owens stepping up to lead the company’s next growth phase.

Austal Limited has raised its FY2025 EBIT guidance from $80 million to at least $100 million, driven by robust manufacturing performance and a key submarine modules contract with General Dynamics Electric Boat.

Austal Limited has finalized a Strategic Shipbuilding Agreement with the Commonwealth of Australia, positioning its subsidiary as the nation’s key Tier 2 naval shipbuilder. This long-term pact sets the stage for significant defence vessel construction in Western Australia.

Albion Resources has reported impressive shallow high-grade gold intercepts at its Collavilla Prospect within the Yandal West Gold Project, reinforcing the potential of this emerging gold system. The results support a geological model linking gold mineralisation to mafic rafts in granite, with further drilling and surveys underway.

Universal Biosensors reported a 44% increase in net loss to A$10.45 million for H1 2025, alongside an 11% revenue decline, raising serious going concern doubts. The company is pursuing an A$8.5 million senior secured loan and equity raise to sustain operations.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Hudson Investment Group faces intense scrutiny from ASX after its auditor issued a Disclaimer of Opinion on the 2024 financial report, citing doubts over a $2.4 million property receivable and the company’s going concern status.

The Lederer Group has made an unsolicited off-market takeover offer for Elanor Commercial Property Fund at 70 cents per security, prompting the Fund's board to carefully consider its response.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

HeraMED Limited has raised $1.98 million through a discounted share placement to fund its digital maternity care platform's commercial growth across the US, Australia, and Europe.